Mini Review
Chimeric Antigen Receptor T-Cell Therapy in Systemic Lupus Erythematosus and Lupus Nephritis; A Promising Approach to Targeting Autoreactive B Cells
Author(s):
Chanchal Maheshwari*, Shehroz Khan, Lajwanti Bai, Aakash Lakhani, Sadiya Aziz Nathani, Aadesh Kumar, Sarah Aoun and Tehreem Fatima
Systemic Lupus Erythematosus (SLE) poses significant challenges due to its life-threatening nature and the prevalence of lupus nephritis, which causes serious kidney damage. Traditional therapies, such as immunosuppressive medications and blocking antibodies, have had limited success, necessitating the development of novel therapeutic strategies. Chimeric Antigen Receptor T-cell therapy (CAR-T) targets autoreactive B cells and reduces disease activity, and offers promising results for improving disease outcomes, improving survival, and decreasing morbidity and mortality. In this review article, we aim to highlight the potential of CAR-T cell therapy in treating the autoimmune processes that underlie SLE and lupus nephritis.
This review article investigates and assesses the indings, usage in treating diseases and predicting its future consequences. We examine current studies .. Read More»
Select your language of interest to view the total content in your interested language
Annals of Medical and Health Sciences Research received 24805 citations as per google scholar report
The Annals of Medical and Health Sciences Research is a monthly multidisciplinary medical journal.